Tal Dror Cohen, MD, is a third year pediatric fellow at Memorial Sloan-Kettering Cancer Center in New York, and the newest participant in the Margaux’s Miracle Foundation Fellowship. Her research is focused on a gene therapy strategy to enhance the persistence of antitumor efficacy of human chimeric antigen receptor (CAR)-modified NK cells for childhood cancer.
Dr. Cohen shares her thoughts on the fellowship below:
Dear Margaux’s Miracle Foundation and the family of sweet Margaux Grossman,
I would like to express my sincerest gratitude to you for establishing the Margaux Grossman Fellowship at Memorial Sloan Kettering. In learning about Margaux from the foundation website I can see she was a truly special young woman that is continuing to leave a positive lasting impression on her loved ones and on other children battling cancer.
I feel humbled and honored to receive this title and hope that together we can achieve our common goal of making miracles happen for the children with cancer who need them the most.
Thank you so much
With love,
Tal Cohen
Read Dr. Cohen’s project description here.